Byu Scholarsarchivemetadata only
SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Comparative Review of Efficacy, Cardiovascular and Renal Benefits, and Cost
sodium-glucose transporter 2 inhibitors, cost-benefit analysis, glycemic control, renal insufficiency, cardiovascular system, nursing
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 179740
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.